Plunkett Research Online: Viralytics Ltd

VIRALYTICS LTD (VRACY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Viralytics, Ltd. is an Australian biotechnology company focusing on developing oncolytic virotherapy for the treatment of a range of cancers. The company’s principal asset is the intellectual property relating to CAVATAK, an oncolytic virus technology. Its current product development pipeline incl.....



Viralytics Ltd
Ticker: VRACY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 299884000
Fax: 61 299880999
Address: 66 Hunter Street
Suite 305, Level 3
Sydney, NSW 2000 Australia

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription

Viralytics, Ltd. is an Australian biotechnology company focusing on developing oncolytic virotherapy for the treatment of a range of cancers. The company’s principal asset is the intellectual property relating to CAVATAK, an oncolytic virus technology. Its current product development pipeline incl.....See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: